Talzenna 0.25 mg
Talzenna 0.25 mg is a medicine authorised by Swissmedic under authorisation number 67141. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 12 December 2019 and the authorisation is valid without a time limit. ATC code L01XK04 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67141 |
|---|---|
| Name | Talzenna 0.25 mg |
| Full name | Talzenna 0.25 mg, Hartkapseln |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XK04 |
| First authorisation | 12 December 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Talzenna 0.25 mg, Hartkapseln | A | 12 December 2019 |
| 2 | Talzenna 1 mg, Hartkapseln | A | 12 December 2019 |
| 3 | Talzenna 0.1 mg, Hartkapseln | A | 12 July 2024 |
| 4 | Talzenna 0.35 mg, Hartkapseln | A | 12 July 2024 |
| 5 | Talzenna 0.5 mg, Hartkapseln | A | 12 July 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 30 | Kapsel(n) | L01XK04 | 07.16.1. | A |
| 6 | 30 | Kapsel(n) | L01XK04 | 07.16.1. | A |
| 7 | 30 | Kapsel(n) | L01XK04 | 07.16.1. | A |
| 8 | 30 | Kapsel(n) | L01XK04 | 07.16.1. | A |
| 9 | 30 | Kapsel(n) | L01XK04 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Talzenna 0.25 mg authorised in Switzerland?
Yes. Talzenna 0.25 mg is authorised by Swissmedic under authorisation number 67141, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Talzenna 0.25 mg have?
Talzenna 0.25 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Talzenna 0.25 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.